Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2024

Discontinued Operations and Disposal Groups [Abstract]

Summary of Financial Statements Related to Discontinued Operations

The results of discontinued operations are as follows (in thousands):

	Three Months Ended March 31,
	2024		2023
Revenues:
Medical services revenue	$	—	$	81,711
Other operating revenue	—		124
Total revenues	—		81,835
Expenses:
Medical services expense	—		75,255
Other medical expenses	—		2,407
General and administrative	518		(2,906)
Depreciation and amortization	—		1,235
Income (loss) from operations	(518)		5,844
Other income (expense), net	—		204
Gain (loss) on sales of assets, net	(8,763)		—
Interest expense	—		(40)
Net income (loss) from discontinued operations attributable to common shares	$	(9,281)	$	6,008

The following table provides significant non-cash operating items for discontinued operations that are included in the consolidated statements of cash flows for the three months ended March 31, 2023 (in thousands):

Non-cash operating activities from discontinued operations:
Depreciation and amortization	$	1,235
Stock-based compensation expense	87